Ana M. Llanos-Brokate

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Inhibition of acid sphingomyelinase increases SMN levels and connects sphingolipid metabolism to Spinal Muscular Atrophy.

Inhibition of acid sphingomyelinase increases SMN levels and connects sphingolipid metabolism to Spinal Muscular Atrophy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 22, 2025

Monosaccharides improve symptoms of an animal model for type III galactosemia, through the activation of the insulin pathway.

Monosaccharides improve symptoms of an animal model for type III galactosemia, through the activation of the insulin pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 25, 2024

Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease.

Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease.

Journal: G3 (Bethesda, Md.)

Published: December 23, 2023

ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing.

ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing.

Journal: Briefings in functional genomics

Published: September 07, 2023

A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease.

A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: June 06, 2023

Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways.

Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2021

Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators.

Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators.

Journal: Briefings in bioinformatics

Published: August 14, 2020

Using AnABlast for intergenic sORF prediction in the Caenorhabditis elegans genome.

Using AnABlast for intergenic sORF prediction in the Caenorhabditis elegans genome.

Journal: Bioinformatics (Oxford, England)

Published: April 07, 2020

Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases.

Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases.

Journal: Nature communications

Published: January 18, 2019

Cytoplasmic LSM-1 protein regulates stress responses through the insulin/IGF-1 signaling pathway in Caenorhabditis elegans.

Cytoplasmic LSM-1 protein regulates stress responses through the insulin/IGF-1 signaling pathway in Caenorhabditis elegans.

Journal: RNA (New York, N.Y.)

Published: April 27, 2015

Developmental defects in a Caenorhabditis elegans model for type III galactosemia.

Developmental defects in a Caenorhabditis elegans model for type III galactosemia.

Journal: Genetics

Published: October 10, 2014

Escherichia coli carbon source metabolism affects longevity of its predator Caenorhabditis elegans.

Escherichia coli carbon source metabolism affects longevity of its predator Caenorhabditis elegans.

Journal: Mechanisms of ageing and development

Published: February 13, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026